Medication Therapy Management Pharmacist

Walgreens is closing fewer than 100 stores in 2026, significantly scaling back from its original plan to shutter approximately 1,200 underperforming locations. The drugstore chain's new owner, private equity firm Sycamore Partners, revised the closure strategy after completing its acquisition in August 2025. Several hundred stores had already closed before the acquisition. The company confirmed around a dozen recent or upcoming closures to USA Today, including locations in Washington DC, Illinois, Missouri, New Jersey, New York, South Carolina, Texas, Virginia, Washington state, and Wisconsin. At the time of acquisition, Walgreens operated 8,500 US locations. The chain currently lists approximately 8,000 stores. Sycamore Partners has previously acquired retailers including Staples, Talbots, and Nine West.

Prime Therapeutics names Manmohan Mahajan CFO. Prime Therapeutics has named Manmohan Mahajan as chief financial officer, confirming the Manmohan Mahajan Prime Therapeutics CFO appointment for a pharmacy benefit manager collectively owned by 19 Blue Cross Blue Shield plans. Where Manmohan Mahajan Prime Therapeutics CFO Mahajan came from. Mahajan most recently served as executive vice president and global CFO at Walgreens Boots Alliance, according to a Sept. 10 news release. He joined WBA in 2016 and held several global senior finance roles before his CFO appointment, including vice president of global reporting and technical accounting, assistant global controller, and senior vice president, global controller and chief accounting officer. His path to WBA's top finance role. Mahajan was named interim global CFO in July 2023 following James Kehoe's departure, and was appointed to the permanent role in March 2024. In that capacity, WBA credited him with playing an integral role in leading the company's growth and cost discipline efforts, including a focused approach to increasing cash flow by lowering capital expenditures. Mahajan's background before joining Walgreens Boots Alliance. Prior to WBA, Mahajan spent 13 years at GE Capital in roles of increasing responsibility, most recently serving as controller at GE Capital Americas. He began his career in public accounting in India, including a stint at PwC, before moving into corporate finance roles in the U.S. Why this trajectory fits a PBM CFO role. Mahajan's experience overseeing global controllership, reporting, and cost-discipline functions at a large, publicly traded pharmacy-led health and retail enterprise gives him direct exposure to the intersection of pharmacy operations and complex financial management, a background that translates naturally to Prime Therapeutics' role as a pharmacy benefit manager. What Prime Therapeutics is within this Manmohan Mahajan Prime Therapeutics CFO announcement. Prime is collectively owned by 19 Blue Cross Blue Shield plans. This ownership structure distinguishes Prime from many other pharmacy benefit managers in the market, which are more commonly owned by large national insurers or standalone PBM companies rather than a consortium of regional nonprofit Blues plans. Why this ownership model shapes the CFO role. Serving as CFO for an organization collectively owned by 19 separate Blue Cross Blue Shield plans likely requires balancing the distinct financial priorities and expectations of multiple regional owner-stakeholders simultaneously, a governance dynamic different from what Mahajan navigated at a single, publicly traded corporation like WBA. How this fits a broader wave of payer executive moves. This appointment adds to a cluster of payer leadership changes reported the same week, including UnitedHealthcare naming a new Washington state COO, Aetna's chief medical officer for Medicare departing, and L.A. Care Health Plan naming a new chief of government relations and external affairs. Why this clustering of appointments matters. The concentration of multiple significant payer and pharmacy benefit manager executive appointments within the same short window suggests this period represents an active season of leadership transitions across the broader payer industry, extending well beyond Prime Therapeutics alone. What this Manmohan Mahajan Prime Therapeutics CFO appointment means going forward. With Mahajan's extensive experience managing cost discipline and financial reporting at a major pharmacy-led enterprise, Prime Therapeutics gains a CFO whose background may prove directly relevant to navigating the financial pressures facing pharmacy benefit managers industry-wide. Given his track record at WBA of aligning cost structure with business performance, Prime's 19 Blue Cross Blue Shield plan owners may look to Mahajan to bring similar financial discipline to the PBM's own operations. What to watch going forward. As Mahajan settles into this role, industry observers will likely watch how his pharmacy retail and cost-management background shapes Prime Therapeutics' financial strategy amid continued scrutiny of pharmacy benefit manager pricing and rebate practices nationally. Given the broader wave of payer executive transitions occurring across the industry this week, this Manmohan Mahajan Prime Therapeutics CFO appointment reflects a wider trend of healthcare organizations recruiting finance leaders with deep pharmacy and retail sector experience as PBMs face mounting regulatory and competitive pressure.

September program calendar. EACM is partnering with Walgreens to offer a FREE vaccine clinic on Tuesday, Sept. 22, from 9:30am - 2pm. This includes both Flu and COVID-19 vaccines. Walk-ins are welcome, but Eastern Area Community Ministries Inc recommend reserving your spot by signing up in the EACM lobby. Here's the full September program calendar: September 2, 2026